CASE: “JD” (identifying details have been changed), a 15-year-old Afro-Caribbean female sophomore student diagnosed with attention-deficit hyperactivity disorder (ADHD), was referred to an Adolescent Substance Use and Addiction Program after substance use disorder screening indicated a positive result, suggesting significant risk. The screening was part of a routine checkup by her primary care provider after noticeable declines in her academic performance and mood. Previously a consistent student, JD's struggles with inattention, forgetfulness, and organizational challenges had become increasingly apparent. Teachers reported that JD seemed perpetually distracted, disengaged, and frequently excused herself to the bathroom. “It's like I'm there, but not really there,” JD explained during an evaluation, describing how disconnected she felt from her surroundings. Moreover, her involvement in extracurricular activities such as the debate club and soccer had waned, changes she vaguely attributed to “lack of energy.” JD's mother described the transformation as watching her daughter “slip away into someone unrecognizable. Every day brings a new worry.” At home, JD's mother discovered JD vaping and found what appeared to be drug paraphernalia in her backpack. Distraught, she confided the ongoing strain these discoveries placed on the family. This period marked a significant emotional toll on the family, accentuating the urgent need for intervention. The sense of loss felt by JD's family was compounded by their fear of her potential decline into more dangerous behaviors, especially given that JD's maternal uncle died of an unintentional opioid-involved overdose. In the initial consultation, JD was reticent to talk about her substance use but gradually disclosed her regular use of cannabis and nicotine via vaping. JD explained that nicotine temporarily enhanced her focus, whereas cannabis provided relief from overwhelming stress, albeit occasionally accompanied by episodes of paranoia. “Sometimes it feels like it's the only thing that calms things down in my head,” JD admitted. She voiced a readiness to quit nicotine but showed ambivalence about changing her cannabis use. Despite the adverse effects, JD perceived these substances as benign when compared with other drugs or alcohol (“weed is natural”). Complicating the clinical picture, JD viewed her friends as support pillars, contrary to her parents' beliefs that these relationships exacerbated her substance use. Her parents advocated for a strict regimen of abstinence from all substances and a complete disassociation from her friends. “They think my friends are the problem, but they're not,” JD contested. The cultural dimensions of JD's identity significantly influenced her engagement with treatment. JD articulated her desire for a treatment approach that respected her and asked for a clinician who could “see where I'm coming from… someone who understands me, not someone who just wants to change me.” Considering JD's ADHD diagnosis, her escalating substance use, and the socio-cultural factors influencing her behavior, what approaches could best address the interplay of these elements to foster a holistic and effective treatment plan for her?
Simon et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: